Key financial metrics and fundamentals for Taysha Gene Therapies, Inc. (TSHA).
Market Cap
$1.39B
P/E Ratio
-15.64
Forward P/E
--
EPS
$-0.35
Forward EPS
Dividend Yield
Beta
Revenue
52-Week Low
52-Week High